Altaris to acquire Simulations Plus for $375 million
Acquiring Company
Altaris
Acquired Company
Simulations Plus
New York
LancasterHealth CareVenture CapitalDescription
Altaris, LLC has announced its plan to acquire Simulations Plus, Inc. for approximately $375 million in an all-cash deal. Stockholders of Simulations Plus will receive $18.50 per share, which represents a 26% premium. The acquisition is poised to accelerate Simulations Plus' growth, especially when combined with Chemical Computing Group. The transaction is expected to close in the fourth quarter of 2026.
Don't miss Altaris's next move
Get an email the moment Altaris makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Simulations Plus?
Simulations Plus was acquired by Altaris, based in New York. The deal was reported on June 16, 2026. Altaris is a healthcare investment firm with an exclusive focus on building companies that deliver value to the healthcare system through innovation and efficiency. Altaris is privately held and operates in Health Care.
When did Altaris acquire Simulations Plus?
Altaris's acquisition of Simulations Plus was reported on June 16, 2026. Altaris, LLC has announced its plan to acquire Simulations Plus, Inc. for approximately $375 million in an all-cash deal. Stockholders of Simulations Plus will receive $18.50 per share, which represents a 26% premium. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Simulations Plus do?
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. It is publicly traded (SLP), and is based in Lancaster.